Media & Resources

Tomorrow, people around the world will pause to mark the 27th annual World AIDS Day with a renewed commitment to ending the epidemic. In New York City, five diverse leaders of the fight against AIDS will gather to hold an engaging conversation about what it will take to defeat HIV/AIDS in our lifetimes. HIV has…

Identifying essential factors for both researchers and CBOs to consider in the design, conduct, implementation, validation, and dissemination of studies in order to protect the rights and safety of study participants.

The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Francine Ntoumi, Founder, Chair and Executive Director of the Congolese Foundation for Medical Research, has joined its Board of Directors. “We are very pleased to welcome Dr. Ntoumi to IAVI’s Board,” said IAVI Board Chair Alex Coutinho. “Her pioneering work in infection research and…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) will provide product development expertise and laboratory assessment support to a new research consortium announced today called the European AIDS Vaccine Initiative (EAVI2020). Funded by a European Union grant under the Horizon 2020 health program, the consortium unites 22 public organizations and biotech companies across Europe,…

MedImmune is the newest member of the Human Vaccines Project, which will help to accelerate the research and development of vaccines and immunotherapies for infectious disease and cancer.

NEW YORK – AUGUST 12, 2015 – The Board of Directors of the International AIDS Vaccine Initiative (IAVI) announced today that Mark Feinberg, MD, PhD, has been appointed IAVI’s new President and CEO, effective 8 September 2015. “Mark brings a wealth of relevant experience and the passion to lead IAVI through the next chapter of…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has made significant contributions to strengthening health research systems in East Africa, according to a study published by RAND Europe on 30 July. In order to develop effective AIDS vaccines for use throughout the world, it is essential to build partnerships and bolster capacity to conduct…

NEW YORK – The latest data from the HIV Vaccines and Microbicides Resource Tracking Working Group highlights concerning trends in funding for vaccine-related research and development. Among the report’s key findings: There’s a flat trend in AIDS vaccine R&D investment. While funding for crucial HIV treatment and prevention programs in low- and middle-income countries is…